Skip to main content
. 2021 Aug 16;53(8):2421–2434. doi: 10.1016/j.transproceed.2021.08.019

Fig 2.

Fig 2

Synthesis of structured review results assessing SARS-CoV-2 infections in solid organ transplant recipients. Our structured review comprises 3451 cases of SOT recipients with confirmed SARS-CoV-2 infection (SARS-CoV-2+) and/or COVID-19 presented as a synopsis (respective source data are available from the authors). (A) The pie chart depicts % fractions of infected SOT recipients (subdivided into liver, lung, heart, and multiple organs). (B) Assigns numbers and % fractions of infected SOT recipients according to the local origin of the reports/their site of treatment. (C) Presents respective SOT recipients according to treatment, categorized either as hospitalized or as outpatient, as well as outcomes at the time of reporting, categorized into deceased/recovered and ongoing treatment. (D) Clinical outcomes of SOT recipients are presented as % fractions and numbers of patients among all cases requiring ICU admission, changes in immunosuppression, and patients experiencing an impaired transplant function linked to infection. COVID-19, coronavirus disease 2019; ICU, intensive care unit; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; SOT, solid organ transplant.